Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China

BACKGROUND: High prices of anticancer medicines have increased the economic burden for both patients and health insurance systems. Since 2017, China has implemented national price negotiations for medicines, relying on evidence from health technology assessments. We aim to assess the relation betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichen, Wei, Yuxuan, Li, Huangqianyu, Chen, Yixuan, Guo, Yiran, Han, Sheng, Shi, Luwen, Guan, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270265/
https://www.ncbi.nlm.nih.gov/pubmed/35764914
http://dx.doi.org/10.1007/s40273-022-01161-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270265/
https://www.ncbi.nlm.nih.gov/pubmed/35764914
http://dx.doi.org/10.1007/s40273-022-01161-7

Ejemplares similares